COHANCE LIFESCIENCES
Back to Cashflow Statement
|
COHANCE LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹368 Cr | ₹673 Cr | ₹385 Cr | ₹457 Cr | ₹330 Cr |
What is the latest Cash Flow from Operating Activities ratio of COHANCE LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹368 Cr |
| Mar2025 | ₹673 Cr |
| Mar2024 | ₹385 Cr |
| Mar2023 | ₹457 Cr |
| Mar2022 | ₹330 Cr |
How is Cash Flow from Operating Activities of COHANCE LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹368 Cr | -45.30 | |
| Mar2025 | ₹673 Cr | 75.00 | |
| Mar2024 | ₹385 Cr | -15.84 | |
| Mar2023 | ₹457 Cr | 38.54 | |
| Mar2022 | ₹330 Cr | - | |
Compare Cash Flow from Operating Activities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,563.3 Cr | 4.2% | 8.4% | -49.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 4.2% |
8.4% |
-49.4% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses